Cargando…
The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment
Platinum-based chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common dose-limiting effects of cancer treatment and results in dose reduction and discontinuation of life-saving chemotherapy. Its debilitating effects are often permanent and lead to lifelong impairment of quality...
Autores principales: | Acklin, Scarlett, Xia, Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921932/ https://www.ncbi.nlm.nih.gov/pubmed/33671279 http://dx.doi.org/10.3390/ijms22041975 |
Ejemplares similares
-
Nicotinamide riboside alleviates cisplatin-induced peripheral neuropathy via SIRT2 activation
por: Acklin, Scarlett, et al.
Publicado: (2022) -
Depletion of senescent-like neuronal cells alleviates cisplatin-induced peripheral neuropathy in mice
por: Acklin, Scarlett, et al.
Publicado: (2020) -
Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
por: Kiss, Robert Csaba, et al.
Publicado: (2021) -
Role of Nucleotide Excision Repair in Cisplatin Resistance
por: Duan, Mingrui, et al.
Publicado: (2020) -
Role of the DNA Base Excision Repair Protein, APE1 in Cisplatin, Oxaliplatin, or Carboplatin Induced Sensory Neuropathy
por: Kelley, Mark R., et al.
Publicado: (2014)